The proportion of patients receiving calcium-based phosphate binders varied over time between 47 and 51%; the proportion of patients receiving non-calcium-based phosphate binders had an increasing trend from 42% at month −3 to 53% at month 12.
← all excerpts
Management of secondary hyperparathyroidism: practice patterns and outcomes of cinacalcet treatment with or without active vitamin D in Austria and Switzerland - the observational TRANSIT Study.
1
—
—